@article{10541,
  keywords = {Administration, Inhalation, Adrenal Cortex Hormones, Adrenergic beta-2 Receptor Agonists/therapeutic use, Bronchodilator Agents, Drug Therapy, Combination, Humans, Middle Aged, Muscarinic Antagonists/therapeutic use, *Pneumonia/epidemiology/etiology, *Pulmonary Disease, Chronic Obstructive/complications, COPD exacerbations, Databases, long-acting bronchodilators, new user cohort design, observational research, pneumonia, real-world evidence},
  author = {S. Suissa and S. Dell'Aniello and P. Ernst},
  title = {Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice},
  year = {2022},
  journal = {Copd},
  volume = {19},
  edition = {2022/04/09},
  number = {1},
  pages = {133-141},
  isbn = {1541-2563},
  doi = {10.1080/15412555.2022.2045265},
  note = {1541-2563
Suissa, Samy
Orcid: 0000-0002-1281-5296
Dell'Aniello, Sophie
Ernst, Pierre
Orcid: 0000-0001-9983-3608
Journal Article
England
COPD. 2022;19(1):133-141. doi: 10.1080/15412555.2022.2045265.},
  language = {eng},
}